Sartorius (OTCMKTS:SARTF) Short Interest Down 49.9% in July

Sartorius (OTCMKTS:SARTF) was the target of a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 458 shares, a decline of 49.9% from the July 15th total of 915 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Currently, 0.0% of the company’s shares are sold short.

Sartorius Price Performance

SARTF opened at $212.80 on Friday. Sartorius has a 52-week low of $181.58 and a 52-week high of $227.00. The company has a 50 day moving average of $211.83 and a two-hundred day moving average of $218.61. The company has a market cap of $7.28 billion, a P/E ratio of 98.98 and a beta of 0.98. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89.

About Sartorius

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.